| Literature DB >> 34888280 |
Min Shen1, Yun Shi1, Shuai Zheng1, Hongqi Fan1, Jingjing Xu1, Tao Yang1.
Abstract
Background: It is important that physicians be aware of LH. We designed a questionnaire to determine physician awareness, knowledge, and behaviors regarding LH in clinical practice. Participants: A total of 499 questionnaires were completed by physicians in hospitals from 13 cities in Jiangsu Province, China. KeyEntities:
Keywords: diabetes; diagnosis-treatment-care processes; lipohypertrophy; physician; questionnaire-based survey
Mesh:
Year: 2021 PMID: 34888280 PMCID: PMC8650682 DOI: 10.3389/fpubh.2021.738179
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Survey administration. (A) 499 physicians in 13 cities of Jiangsu province completed the survey. (B) Comparison of the participating physicians. (C) Physician seniority composition.
Figure 2Recognition of lipohypertrophy. (A) Proportions of physicians who reported awareness of LH. (B) Proportions of physicians aware of LH according to the GDP per capita of the region their hospital serves. (C) Proportions of physicians aware of LH according to different professional titles.
Insights into LH awareness according to the different hierarchical medical systems.
|
|
|
|
|
|
|---|---|---|---|---|
|
|
|
| ||
|
| ||||
| Claimed to be aware of LH | 94.1% | 93.9% | 81.1% | 0.000 |
| Recognized LH as a local complication of insulin therapy | 75.5% | 67.3% | 71.6% | >0.05 |
| Recognized LH as important for diabetes management | 95.8% | 94.9% | 89.5% | 0.081 |
| Claimed awareness of LH screening methods | 69.9% | 59.2% | 52.6% | 0.004 |
|
| ||||
| Associated risk factors (score 5) | 40.0% | 40.8% | 36.8% | 0.472 |
| Clinical impacts (score 7) | 45.8% | 35.7% | 18.9% | 0.041 |
|
| ||||
| Management process | 82.4% | 59.2% | 54.7% | 0.000 |
| Checked the insulin injection site regularly | 79.1% | 80.6% | 70.5% | 0.171 |
| Educated patients about LH | 85.9% | 84.7% | 74.7% | 0.041 |
Figure 3Lipohypertrophy screening method.
Figure 4Risk factors associated with lipohypertrophy.
Figure 5Clinical impacts of lipohypertrophy.